MALIN CORPORATION PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.7 EUR | -.--% |
|
-3.39% | +26.67% |
| May. 01 | Malin Corp investee signs agreement with Astellas Pharma | AN |
| Mar. 28 | Transcript : Malin Corporation plc - Shareholder/Analyst Call |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 117M | - | - | - | - | - | |
| 739B | ||||||
| 598B | ||||||
| 353B | ||||||
| 318B | ||||||
| 285B |
